Medicine
fromwww.theguardian.com
3 days agoThe Guardian view on gene editing: breakthroughs need a new social contract | Editorial
Few genes cause thousands of rare disorders, yet high drug-development costs and weak commercial incentives leave most genetic conditions without scalable therapies.